tirzepatide cardiovascular outcomes trial results july 2025 Comparison of tirzepatide and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: SURPASS‐CVOT design and Tirzepatide for Heart Failure with
Description
Expect check-ins to assess how youre feeling, consider dose changes, and discuss lifestyle supports
Foods to Avoid When Prone to Sulfur Burps Certain foods are notorious triggers worth avoiding if youre susceptible to sulfur burps
On this measure, average weight loss at 80 weeks was 19.0% on 4 mg, 25.9% on 9 mg and 28.3% on 12 mg, compared with 2.2% on placebo
Researchers selecting between these compounds should base their choice on the specific metabolic pathway or endpoint their study is designed to investigate
doi: 10.1523/JNEUROSCI.4920-04.2005
